Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Plasma Amyloid Beta Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment: the BALTAZAR Study.

Olivier Hanon,Jean-Sebastien Vidal,Sylvain Lehmann,Stephanie Bombois,Bernadette Allinquant, Christiane Baret-Rose,Jean-Marc Treluyer,Hendy Abdoul,Patrick Gele,Christine Delmaire,Frederic Blanc,Jean-Francois Mangin,Luc Buee,Jacques Touchon,Jacques Hugon,Bruno Vellas,Evelyne Galbrun,Athanase Benetos,Gilles Berrut,Elena Paillaud,David Wallon,Giovanni Castelnovo,Lisette Volpe-Gillot,Marc Paccalin,Philippe Robert,Olivier Godefroy,Vincent Camus,Joel Belmin,Pierre Vandel,Jean-Luc Novella,Emmanuelle Duron,Anne-Sophie Rigaud,Susanna Schraen-Maschke,Audrey Gabelle

Alzheimer's & Dementia（2022）

Cited 14|Views37
No score
Abstract
Blood‐based biomarkers are the next challenge for Alzheimer's disease (AD) diagnosis and prognosis.
More
Translated text
Key words
Alzheimer's disease,amyloid beta protein,cerebrospinal fluid,major neurocognitive disorder,mild cognitive impairment,minor neurocognitive disorder,plasma biomarkers,prognosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined